StarkRx Unbundles the PBM for 2.5 Million Employer-Sponsored Lives

The unbundling of employer healthcare is moving deeper into pharmacy benefits.

Employers Health and Judi Health have launched StarkRx, a transparent, cost-plus pharmacy benefit designed for self-funded plan sponsors that want more control over how their pharmacy benefit is assembled.

The model is notable because it does not simply promise a more transparent version of a traditional PBM contract.

StarkRx is explicitly modular.

Plan sponsors can use Judi Rx and the Judi platform as the underlying PBM infrastructure while choosing among different specialty-management providers, pharmacy networks, plan designs and direct-to-consumer purchasing channels.

That architecture matters because Employers Health already represents significant purchasing scale: the employer-founded organization says its programs serve more than 500 clients, cover 2.5 million lives and represent nearly $6.1 billion in annual pharmacy spend.

This is employer healthcare unbundling at PBM scale.

From one PBM contract to a pharmacy stack

Traditional pharmacy benefits bundle several functions together.

The PBM typically manages the retail network, formulary, rebates, claims processing, specialty pharmacy, utilization management and other services under one commercial relationship.

StarkRx separates more of those components.

Employers Health says the model provides a broad retail pharmacy network using cost-plus reimbursement, while giving plan sponsors flexibility to work with third-party solution providers for specialty drug management.

The initial offering specifically identifies Archimedes as one specialty-management option.

StarkRx also includes a cost-plus specialty pharmacy network that includes Amazon Pharmacy and Accredo by Evernorth.

The underlying technology and PBM infrastructure are anchored by Judi Health, including Judi Rx and the Judi enterprise platform.

The result looks less like buying a single PBM product and more like assembling a pharmacy-benefit stack.

The economics are designed to be visible

Transparency is central to the product design.

StarkRx says compensation is based on flat administrative fees and includes NDC-level rebate reporting, giving plan sponsors visibility into drug-level economics.

Its retail network uses full pass-through and acquisition-cost-based pharmacy reimbursement.

For specialty drugs, the model combines cost-plus reimbursement with independent prior authorization.

And formularies are designed to prefer the lowest-net-cost medication, rather than optimizing around average rebate or brand guarantees.

Those distinctions matter because the incentives inside a pharmacy contract can determine which drugs are preferred, which pharmacies receive volume and where the economic margin sits.

A plan sponsor that can see acquisition cost, administrative compensation and rebates separately has more information with which to evaluate those decisions.

Direct-to-consumer becomes part of the benefit

One of the most interesting StarkRx capabilities is its explicit support for direct-to-consumer access.

Employers Health says StarkRx can integrate direct-to-consumer platforms with benefit plans.

That places the launch alongside another development DirectContract recently covered: Navitus DirectAccess, which creates an off-benefit pathway for weight-management GLP-1 drugs.

The two approaches are not identical.

But they point toward the same structural change.

The pharmacy benefit no longer has to be the exclusive purchasing channel for every prescription.

An employer can maintain PBM infrastructure for the broad benefit while routing particular drugs or categories through alternative purchasing mechanisms when the economics are more attractive.

That is the pharmacy equivalent of an employer retaining a national medical network while using direct primary care, centers of excellence, specialty carve-outs or direct provider contracts for selected categories.

Incumbent infrastructure can support its own unbundling

The pharmacy market is often described as a choice between incumbent PBMs and new alternatives.

StarkRx suggests the architecture may become more nuanced.

Employers Health already works with large PBM suppliers including CVS Health, Optum Rx and MedImpact. Its new model adds Judi Health as infrastructure for a more modular purchasing approach.

Rather than replacing every function with one new vendor, the employer can choose which components it wants to separate.

That could include specialty management.

It could include a cost-plus pharmacy network.

It could include independent utilization management.

It could include direct-to-consumer purchasing.

And it could change over time without forcing the employer to rebuild the entire benefit.

That flexibility is strategically important in a pharmacy market where GLP-1s, specialty drugs, biosimilars and manufacturer-direct channels are changing rapidly.

2.5 million lives creates meaningful distribution

The scale behind Employers Health makes StarkRx more important than a typical PBM startup launch.

Employers Health says it works with 500+ plan sponsors nationwide and covers more than 2.5 million lives.

It reports nearly $6.1 billion in projected annual pharmacy spend across its clients.

That does not mean 2.5 million people are enrolled in StarkRx.

StarkRx is a new offering, and Employers Health has not disclosed how many existing clients have selected it.

But the existing purchasing coalition gives the model a large distribution base.

If even a portion of those employers migrate toward modular cost-plus arrangements, Employers Health could provide a useful test of whether transparent PBM architecture can move beyond individual early adopters and into a scaled employer purchasing coalition.

The employer-healthcare stack keeps becoming more modular

The pattern now extends well beyond pharmacy.

Nara Health is building TPA infrastructure around alternative self-funded plan designs.

Angle Health is distributing alternative networks and cost-containment programs to thousands of smaller employers.

World Class Health is extending the center-of-excellence model into specialty infusion.

VensureHR is embedding direct primary care into the HR and benefits stack.

And Navitus is creating a parallel purchasing channel for GLP-1s outside the conventional pharmacy benefit.

StarkRx pushes the same logic into the core PBM contract itself.

Employers increasingly do not have to choose between a completely bundled benefit and managing every vendor independently.

Infrastructure providers are emerging that let them keep a common administrative layer while changing the purchasing mechanism underneath individual categories.

What to watch

The most important next datapoint is adoption.

Employers Health should eventually be able to show how many of its 500+ plan sponsors select StarkRx and how much pharmacy spend migrates onto the model.

The second is specialty.

Specialty drugs account for a disproportionate share of pharmacy costs, so the economics of cost-plus specialty reimbursement and independent prior authorization will be critical.

The third is direct-to-consumer integration.

Manufacturer-direct and cash-pay drug channels are expanding quickly. A PBM architecture that can incorporate those channels rather than compete against them could become increasingly valuable.

And the fourth is measurable net cost.

Transparency is useful, but employers ultimately need to know whether a modular cost-plus model produces lower total pharmacy spending after rebates, administrative fees, specialty costs and utilization are considered.

If StarkRx can demonstrate that at scale, it would represent more than another PBM alternative.

It would show that the pharmacy benefit itself can become modular purchasing infrastructure.

Sources

• Employers Health, “Employers Health and Judi Health Come Together to Offer New Modular PBM Solution: StarkRx,” September 8, 2026: https://www.employershealthco.com/resource-center/articles/employers-health-and-judi-health-come-together-to-offer-new-modular-pbm-solution-starkrx/
• Employers Health, StarkRx product overview: https://www.employershealthco.com/vendors/starkrx/
• Judi Health, “Employers Health and Judi Health Come Together to Offer New Modular PBM Solution: StarkRx,” September 8, 2026: https://www.judi.health/insights/employers-health-and-judi-health-come-together-to-offer-new-modular-pbm-solution-starkrx